MIAMI, April 22, 2020 /CNW/ – Cansortium Inc. (“Cansortium” or the “Company”) (CSE: TIUM.U), (OTCQB: CNTMF) a vertically-integrated provider of premium-quality medical cannabis operating under the Fluent™ brand, continued its Florida expansion, celebrating the April 21st opening of a new dispensary in East Orlando – its 20th Florida dispensary and its third in the Orlando metro area.
The Company’s newest dispensary is located at 10607 E. Colonial Drive, Orlando. The 3,200 square foot site, together with the Company’s existing Downtown Orlando dispensary at 1901 North Orange Avenue, and its Casselberry dispensary at 487 State Road 436, will serve Orlando’s 2.5 million residents and millions of annual tourists. The new site is conveniently located less than 30 miles from Disney World, Universal Studios, International Drive and the Orlando airport and less than 4 miles from the campuses of the University of Central Florida and Valencia College, which have combined enrollments of nearly 90,000 students.
Cansortium’s Executive Chairman Neal Hochberg noted, “We continue to expand our Florida dispensary network, enhancing access to premium-quality Fluent cannabis products for medical marijuana patients across the state. As one of the first five licensed operators in Florida, we are proud to be able to continue serving Florida’s large and growing population of medical marijuana patients through the challenges posed by the COVID-19 pandemic. All of our dispensaries remain open following Florida Governor Ron DeSantis’ April 3, 2020 Stay-at-Home order, which specifically designated medical marijuana as one of several essential services.”
Mr. Hochberg concluded, “The health and safety of our employees, each of the Florida patients and the communities in which we operate is our primary concern. As part of our efforts to help slow the spread of COVID-19 in accordance with guidelines from State and local health authorities, we are prioritizing Express Pick-up orders, including curbside and drive-through pick-up. In addition, each of our 20 locations across the state has implemented additional cleaning and sanitation procedures, as well as social distancing protocols.”
The Fluent brand continually strives to set the standard for premium quality, consistently-formulated cannabis products. Each of the Company’s Florida dispensaries carries a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories. All Fluent products in the Company’s Florida dispensaries use high-quality cannabis that is cultivated, processed and packaged in the company’s state-of-the-art Florida facilities in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.
The new East Orlando dispensary is the Company’s second opening of 2020 and one of several more at various stages of construction and approval that the Company expects to add to its network this year.
For a complete list of Fluent dispensary locations, current promotions and rewards programs and hours of operation, or to explore the entire Fluent product line and place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.
About Cansortium Inc.
Headquartered in Miami, Florida, and operating under the Fluent™ brand, Cansortium is focused on being the highest quality cannabis company in the State of Florida driven by unrelenting commitment to operational excellence from seed to sale. Cansortium has developed strong proficiencies in each of cultivation, processing, retail, and distribution activities, the result of successfully operating in the highly regulated cannabis industry. In addition to Florida, Cansortium is seeking to create significant shareholder value in the attractive markets of Texas, Michigan and Pennsylvania, where the Company has secured licenses and established operations.
Cansortium Inc.’s common shares and warrants trade on the CSE under the symbol “TIUM.U” and “TIUM.WT.U”, respectively, and on the OTCQB Venture Market under the symbol (OTCQB: CNTMF). Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcmarkets.com.
Certain information in this news release, may constitute forward-looking information. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
For further information:
SOURCE Cansortium Inc
For further information: Cansortium Investors and Media: Neal Hochberg, Executive Chairman, email@example.com; 646-752-5736, firstname.lastname@example.org